1. World Health Organization: National cancer control programmes, in Policies and Managerial Guidelines (ed 2). Geneva, Switzerland, WHO, 2002.
2. Smith TJ, Temin S, Alesi ER, et al. American Society of Clinical Oncology provisional clinical opinion: the integration of palliative care into standard oncology care. J Clin Oncol. 2012;30(8):880‑7.
3. Morita T, Akechi T, Ikenaga M, et al. Late referrals to specialized palliative care service in Japan. J Clin Oncol. 2005;23(12):2637‑44.
4. Baek YJ, Shin DW, Choi JY, et al. Late referral to palliative care services in Korea. J Pain Symptom Manage. 2011;41(4):692‑9.
5. Vinant P, Joffin I, Serresse L, et al. Integration and activity of hospital-based palliative care consultation teams: the INSIGHT multicentric cohort study. BMC Palliat Care. 2017;16(1):36.
6. Zimmermann C, Riechelmann R, Krzyzanowska M, et al. Effectiveness of specialized palliative care: a systematic review. JAMA. 2008;299(14):1698‑709.
7. Miyashita M, Hirai K, Morita T, et al. Barriers to referral to inpatient palliative care units in Japan: a qualitative survey with content analysis. Support Care Cancer. 2008;16(3):217‑22.
8. Pfeil TA, Laryionava K, Reiter-Theil S, et al. What keeps oncologists from addressing palliative care early on with incurable cancer patients? An active stance seems key. The Oncologist. 2015;20(1):56‑61.
9. Mack JW, Smith TJ. Reasons why physicians do not have discussions about poor prognosis, why it matters, and what can be improved. J Clin Oncol. 2012;30(22):2715‑7.
10. Hui D, Mori M, Watanabe SM, et al. Referral criteria for outpatient specialty palliative cancer care: an international consensus. Lancet Oncol. 2016;17(12):e552‑9.
11. Temel JS, Jackson VA, Billings JA, et al. Phase II study: integrated palliative care in newly diagnosed advanced non-small-cell lung cancer patients. J Clin Oncol. 2007;25(17):2377‑82.
12. Temel JS, Greer JA, Muzikansky A, et al. Early palliative care for patients with metastatic non-small-cell lung cancer. N Engl J Med. 2010;363(8):733‑42.
13. Zimmermann C, Swami N, Krzyzanowska M, et al. Early palliative care for patients with advanced cancer: a cluster-randomised controlled trial. Lancet Lond Engl. 2014;383(9930):1721‑30.
14. Bakitas MA, Tosteson TD, Li Z, et al. Early Versus Delayed Initiation of Concurrent Palliative Oncology Care: Patient Outcomes in the ENABLE III Randomized Controlled Trial. J Clin Oncol. 2015;33(13):1438‑45.
15. Temel JS, Greer JA, El-Jawahri A, et al. Effects of Early Integrated Palliative Care in Patients With Lung and GI Cancer: A Randomized Clinical Trial. J Clin Oncol. 2017;35(8):834‑41.
16. Maltoni M, Scarpi E, Dall’Agata M, et al. Systematic versus on-demand early palliative care: A randomised clinical trial assessing quality of care and treatment aggressiveness near the end of life. Eur J Cancer. 2016;69:110‑8.
17. Ferrell BR, Temel JS, Temin S, et al. Integration of Palliative Care Into Standard Oncology Care: American Society of Clinical Oncology Clinical Practice Guideline Update. J Clin Oncol. 2017;35(1):96‑112.
18. Dizon DS, Krilov L, Cohen E, et al. Clinical Cancer Advances 2016: Annual Report on Progress Against Cancer From the American Society of Clinical Oncology. J Clin Oncol. 2016;34(9):987‑1011.
19. Hui D, Kim YJ, Park JC, et al. Integration of oncology and palliative care: a systematic review. The Oncologist. 2015;20(1):77‑83.
20. Huillard O, Colombet I, Montheil V, et al. Integration of Oncology and Palliative Care, a Forgotten Indicator: Shared Decision-Making. The Oncologist. 2015;20(9):e26.
21. Colombet I, Montheil V, Durand J-P, et al. Effect of integrated palliative care on the quality of end-of-life care: retrospective analysis of 521 cancer patients. BMJ Support Palliat Care. 2012;2(3):239‑47.
22. Colombet I, Vinant P, Joffin I, et al. [Use of a standard format to describe the activity of hospital-based palliative care team: a lever for improving end of life care]. Presse Medicale. 2015;44(1):e1‑11.
23. Oken MM, Creech RH, Tormey DC, et al. Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol. 1982;5(6):649‑55.
24. Earle CC, Neville BA, Landrum MB, et al. Evaluating claims-based indicators of the intensity of end-of-life cancer care. Int J Qual Health Care. 2005;17(6):505‑9.
25. Rapport 2011 : Un premier état des lieux [Internet]. Observatoire National de la Fin de Vie. Available at. http://www.spfv.fr/sites/default/files/file/PDFRapportONFV2011.pdf. Accessed July 10 2016
26. Hui D, Elsayem A, De la Cruz M, et al. Availability and integration of palliative care at US cancer centers. JAMA. 2010;303(11):1054‑61.
27. Cheng W-W, Willey J, Palmer JL, et al. Interval between palliative care referral and death among patients treated at a comprehensive cancer center. J Palliat Med. 2005;8(5):1025‑32.
28. Gaertner J, Wolf J, Hallek M, et al. Standardizing integration of palliative care into comprehensive cancer therapy--a disease specific approach. Support Care Cancer. 2011;19(7):1037‑43.
29. Steven A, Fisher SA, Robinson BW. Immunotherapy for lung cancer. Respirol Carlton Vic. 2016;21(5):821‑33.
30. Hamard C, Ruppert A-M, Lavole A, et al. [News about targeted therapies in non-small-cell lung cancer in 2015 (except immuno-therapy)]. Ann Pathol. 2016;36(1):63‑72.
31. Hodi FS, O’Day SJ, McDermott DF, et al. Improved survival with ipilimumab in patients with metastatic melanoma. N Engl J Med. 2010;363(8):711‑23.